Familial Mediterranean fever: misdiagnosis and diagnostic delay in Turkey.


Journal

Clinical and experimental rheumatology
ISSN: 0392-856X
Titre abrégé: Clin Exp Rheumatol
Pays: Italy
ID NLM: 8308521

Informations de publication

Date de publication:
Historique:
received: 12 08 2019
accepted: 10 10 2019
pubmed: 7 11 2019
medline: 9 1 2020
entrez: 8 11 2019
Statut: ppublish

Résumé

The diagnosis of familial Mediterranean fever (FMF) can be missed or delayed even in countries where FMF prevalence is high. In this study we investigated the presentation pattern, the frequency of misdiagnosis and the duration of diagnostic delay and its underlying causes in a large cohort followed by a single tertiary centre in Turkey. We studied 197 (118 F, 79 M) consecutive patients with FMF (median age: 34 years [IQR: 27-44]). The median registry year of the patients was 2006 [IQR: 2001-2011]. A standardised questionnaire was used to assess age at first symptom, date at diagnosis, previous diagnosis and treatments before the FMF diagnosis. A total of 167 (84%) patients were misdiagnosed and 56 (28%) underwent surgical operations before FMF diagnosis. The most common mis-diagnoses were appendicitis (55%) and acute rheumatic fever (ARF) (45%). The median duration of diagnostic delay was 11 years. Joint attacks were observed to start at a significantly younger age (median age: 3 years) than abdominal attacks (median age: 12 years). Early onset with solo joint attacks, without usual peritonitis attacks and being a carrier of M694V were found to be significantly associated with ARF misdiagnosis. Misdiagnosis frequency is still significantly high and diagnostic delay is long even in a cohort of patients registered after year 2000 in Turkey. Atypical presentation with solo joint attacks, especially among patients with early onset, seems to play a significant role in misdiagnosis and delay in diagnosis.

Identifiants

pubmed: 31694753
pii: 14648

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

119-124

Auteurs

Mustafa Erdogan (M)

Division of Rheumatology, Department of Medicine, Cerrahpaşa Medical Faculty, University of Istanbul-Cerrahpasa, Istanbul, Turkey.

Serdal Ugurlu (S)

Division of Rheumatology, Department of Medicine, Cerrahpaşa Medical Faculty, University of Istanbul-Cerrahpasa, Istanbul, Turkey.

Huri Ozdogan (H)

Division of Rheumatology, Department of Medicine, Cerrahpaşa Medical Faculty, University of Istanbul-Cerrahpasa, Istanbul, Turkey.

Emire Seyahi (E)

Division of Rheumatology, Department of Medicine, Cerrahpaşa Medical Faculty, University of Istanbul-Cerrahpasa, Istanbul, Turkey. eseyahi@yahoo.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH